NLRP1 Antikörper (AA 2-25)
Kurzübersicht für NLRP1 Antikörper (AA 2-25) (ABIN5690365)
Target
Alle NLRP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2-25
-
Spezifität
- Recognizes human NLRP1/NALP1. Does not cross-react with mouse NLRP1/NALP1.
-
Immunogen
- Synthetic peptide corresponding to aa 2-25 (A2GGAWGRLACYLEFLKKEELKEFQ25) at the N-terminus of human NLRP1/NALP1.
-
-
-
-
Applikationshinweise
- Western Blot: (1:1,000).
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid. In PBS containing 10 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for at least 1 year after receipt when stored at -20°C.
-
-
- NLRP1 (NLR Family, Pyrin Domain Containing 1 (NLRP1))
-
Andere Bezeichnung
- NLRP1/NALP1
-
Hintergrund
- NALP1/NLRP1 is able to form cytoplasmic structures termed death effector filaments. It enhances and stimulates apoptosis through activation of different caspase cascades. It is involved in the activation of caspase-1 and caspase-5 as part of the NALP1 inflammasome complex which leads to processing and release of IL1B and IL18. Genetic variations in the NLRP1/NALP1 gene are associated with susceptibility to vitiligo-associated multiple autoimmune disease type 1, an autoimmune disorder characterized by the association of vitiligo with several autoimmune and autoinflammatory diseases including autoimmune thyroid disease, rheumatoid arthritis and systemic lupus erythematosus.
-
Gen-ID
- 22861
-
UniProt
- Q9C000
-
Pathways
- Positive Regulation of Endopeptidase Activity, Inflammasome
Target
-